Mayla Welford
No ORCID on file
· 1 paper in corpus
· active 2003
OBJECTIVE: To evaluate alendronate as a prophylactic measure against bone mineral density (BMD) loss in reproductive-aged women receiving gonadotropin-releasing hormone agonist (GnRHa) therapy for 6 months. STUDY DESIGN: A randomized, doub…